AusBiotech Updates

Australian life science companies to engage with Asian investors

16 February 2017: Emerging life science companies are encouraged to take advantage of Asias propitious investment landscape and join AusBiotechs Asian Investment Series. The Series will be held in three key Asian investment hubs during March, and is expected to draw ... | READ MORE

TGA Bill to cut 'red tape' stalls for Inquiry

14 February 2017: The passage of a legislative bill to enable regulatory reform measures stemming from the review of Medicines and Medical Devices Regulation (MMDR) was last week delayed with its referral for Inquiry. The Senate has referred the Therapeutic Goods Am... | READ MORE

Last call for abstracts for international research conference on mechanics in medicine and biology

9 February 2017: The International Conference on Mechanics in Medicine and Biology (ICMMB) scientific program committee has made its final call for abstracts, inviting submissions by Friday 17 February 2017. This year AusMedtech 2017 & ICMMB 2017 will be co-presente... | READ MORE

AusBiotech to initiate clinical trials advisory group

7 February 2017: AusBiotech is inviting members to express interest in joining a new advisory group to provide guidance and advice on policy impacting clinical trials (CTs). During 2016, more than 80 AusBiotech members attended invitation-only roundtables discuss is... | READ MORE

AusBiotech consults biotech CEOs on industry advocacy

2 February 2017: AusBiotech has launched its annual consultation of membership issues, calling for leaders of biotechnology companies to respond to the annual CEO Biotechnology Industry Position Survey 2017, as a matter of importance. AusBiotech conducts the confide... | READ MORE

Senate Inquiry on prostheses pricing urged to consider implications

31 January 2017: AusBiotech has made a submission to the Senates Community Affairs References Committee Inquiry into the Price regulation associated with the Prostheses List Framework, urging the Inquiry to carefully consider the impacts of pricing reforms. AusBiote... | READ MORE

Important warning regarding recent fraudulent activity, using AusBiotech’s name

AusBiotech has recently been the subject of misrepresentation in attempts to defraud people. Examples predominately relate to phishing activity and has involved the fraudulent practice of sending emails to inboxes or connection requests through social media sites, pu... | READ MORE

Australia Day celebration of the life sciences industry

26 January 2017: As Australians pause for a day to celebrate and reflect on who and where we are as nation, Australias is positioned well in biotechnology to deliver on its promise for the future as a driver for the Australian economy. The official slogan for the da... | READ MORE

Government seeks further comment on Productivity Commission's intellectual property report

24 January 2017: The Federal Government has invited stakeholder views after releasing the final report on the Productivity Commissions (PC) inquiry into Australia's intellectual property arrangements. The report contains many areas of concern and AusBiotech seeks mem... | READ MORE

AusBiotech submits to TGA on medical device reform

19 January 2017: AusBiotech, supported by the AusMedtech Regulatory Affairs Expert Panel, has submitted to two medical device consultations that form part of the Medicines and Medical Devices Review (MMDR). The consultations seek to streamline medical device assessm... | READ MORE

Jump to page